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Abstract
Objectives—To assess whether the addition of a peer testimonial to an informational mailing
increases conversion rates from brand-name prescription medications to lower-cost therapeutic
equivalents, and whether the testimonial’s efficacy increases when information is added about an
affiliation the quoted individual shares with the recipient.
Research Design and Methods—5,498 union members were randomly assigned to receive
one of three different informational letters: one without a testimonial (No Testimonial Group), one
with a testimonial from a person whose shared union affiliation with the recipient was not
disclosed (Unaffiliated Testimonial Group), and one with a testimonial from a person whose
shared union affiliation with the recipient was disclosed (Affiliated Testimonial Group).
Results—The conversion rate for the No Testimonial Group was 12.2%, which is higher than the
Unaffiliated Testimonial Group rate of 11.3% and the Affiliated Testimonial Group rate of 11.7%.
The differences between the groups are not statistically significant.
Conclusions—Short peer testimonials do not increase the impact of a mailed communication on
conversion rates to lower-cost, therapeutically equivalent medications, even when the testimonial
is presented as coming from a more socially proximate peer.
Keywords
Testimonial; peer information; social proximity; communication; generic medication
Healthcare organizations often try to change individuals’ health behaviors using printed
communications (Sedjo and Cox). We hypothesized that adding a peer testimonial to an
informational letter would significantly increase the letter’s efficacy, and that the
testimonial’s effectiveness would be increasing in the perceived social closeness of the peer
to the recipient. Testimonials may work because individuals imitate their peers (Duflo and
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tSaez; Sacerdote), and studies show that the influence of a peer is increasing in the peer’s
social proximity (Christakis and Fowler; Hoxby; Soetevent and Kooreman).
We conducted a randomized controlled trial to assess whether adding a peer testimonial to a
mailing increases conversions from brand-name prescription medications to lower-cost
equivalents. In coordination with a pharmacy benefit manager (PBM), 5,498 union members
were randomly assigned to receive one of three informational letters. Members were
selected for the study if they had, in the six months prior to May 2011, filled a brand name
prescription that had a cheaper therapeutic equivalent.
Members in the No Testimonial Group received a letter listing cheaper therapeutic
equivalents available for the recipient’s brand name prescription medication and the
associated cost savings to the recipient from switching to each of these alternatives.
Members in the Unaffiliated Testimonial Group received a letter identical to the No
Testimonial letter except for the addition of the following testimonial from a member of
their union: “Switching to a lower-cost generic medication puts money back in my pocket
every month.” Beneath the testimonial appeared the quoted member’s first name, last initial,
city, and state. Members in the Affiliated Testimonial Group received a letter identical to the
Unaffiliated Testimonial letter except for the addition of the quoted member’s union
affiliation below the testimonial.
The letters were sent on May 1, 2011. The PBM measured the targeted members’
prescription drug claims for six months after the mailing.
The conversion rate to lower-cost alternatives for the No Testimonial Group was 12.2%,
which is higher than the Unaffiliated Testimonial Group rate of 11.3% and the Affiliated
Testimonial Group rate of 11.7%. The differences in the conversion rate between the control
and the treatment groups are not statistically significant, and adding demographic controls
does not change the significance or the rank order of the groups’ conversion rates (Table 1,
columns 1–3).
The differences between the control and the treatment groups in the percent of employees
who converted to a cheaper alternative and never reconverted to the brand name are also not
statistically significant, and including demographic controls does not change their
significance (Table 1, columns 4–6).
In conclusion, we find that adding a short peer testimonial to a letter about the benefits of
generic drugs did not increase the likelihood of the recipient converting to a lower-cost
therapeutic alternative, even when the testimonial was marked as coming from a member of
the recipient’s union. These results suggest that organizations need not expend the
considerable effort required to solicit short testimonials from peers of their health
communication recipients.
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